★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Cochlear Limited vs Elekta AB (publ)

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Cochlear Limited

COH · ASX

Market cap (USD)$4.5B
Gross margin (TTM)74.1%
Operating margin (TTM)21.4%
Net margin (TTM)15.3%
SectorHealthcare
IndustryMedical - Devices
CountryAU
Data as of2026-06-03
Moat score
81/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Cochlear Limited's moat claims, evidence, and risks.

View COH analysis

Elekta AB (publ)

EKTA B · NASDAQ Stockholm

Market cap (USD)$2.1B
Gross margin (TTM)37.4%
Operating margin (TTM)5.3%
Net margin (TTM)-3.1%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountrySE
Data as of2026-06-03
Moat score
70/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Elekta AB (publ)'s moat claims, evidence, and risks.

View EKTA B analysis

Comparison highlights

  • Moat score gap: Cochlear Limited leads (81 / 100 vs 70 / 100 for Elekta AB (publ)).
  • Segment focus: Cochlear Limited has 3 segments (61.6% in Cochlear Implants); Elekta AB (publ) has 2 segments (55.8% in Solutions).
  • Moat breadth: Cochlear Limited has 8 moat types across 3 domains; Elekta AB (publ) has 7 across 3.

Primary market context

Cochlear Limited

Cochlear Implants

Market

Cochlear implant systems (internal implant + external sound processors) for severe-to-profound hearing loss

Geography

Global

Customer

Hospitals/ENT clinics and audiology programs (providers) serving implant candidates/recipients; reimbursed by public/private payers

Role

Medical device OEM / platform owner (implant + processor + fitting software + clinical support)

Revenue share

61.6%

Elekta AB (publ)

Solutions

Market

Radiotherapy treatment delivery systems and oncology software solutions (linacs, MR-Linacs, stereotactic radiosurgery, treatment planning & oncology information systems)

Geography

Global

Customer

Hospitals, cancer centers, and clinics (often via public/central procurement)

Role

Medical device OEM + software/platform provider

Revenue share

55.8%

Side-by-side metrics

Cochlear Limited
Elekta AB (publ)
Ticker / Exchange
COH - ASX
EKTA B - NASDAQ Stockholm
Market cap (USD)
$4.5B
$2.1B
Gross margin (TTM)
74.1%
37.4%
Operating margin (TTM)
21.4%
5.3%
Net margin (TTM)
15.3%
-3.1%
Sector
Healthcare
Healthcare
Industry
Medical - Devices
Medical - Instruments & Supplies
HQ country
AU
SE
Primary segment
Cochlear Implants
Solutions
Market structure
Oligopoly
Oligopoly
Market share
60%-65% (reported)
40%-44% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
81 / 100
70 / 100
Moat domains
Demand, Legal, Supply
Supply, Legal, Demand
Last update
2026-06-03
2026-06-03

Moat coverage

Shared moat types

Compliance AdvantageCapex Knowhow ScaleService Field NetworkInstalled Base ConsumablesData Workflow Lockin

Cochlear Limited strengths

Brand TrustIP Choke PointFormat Lock In

Elekta AB (publ) strengths

Procurement InertiaSwitching Costs General

Segment mix

Cochlear Limited segments

Full profile >

Cochlear Implants

Oligopoly

61.6%

Services

Monopoly

26.5%

Acoustics

Oligopoly

11.9%

Elekta AB (publ) segments

Full profile >

Solutions

Oligopoly

55.8%

Service

Quasi-Monopoly

44.2%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.